---
title: "SMMT SEC Filings and Financial Statements | Tradytics"
description: "Annual income statements, balance sheets and cash flows for Summit Therapeutics (SMMT), with links to the SEC filings."
url: "https://tradytics.com/research/SMMT/fundamentals"
image: "https://tradytics.com/api/v2/og/research.png?id=SMMT&v=stock-11994873"
---

# SMMT financial statements and SEC filings

## SMMT annual income statement

| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | – | – | -$1.08B | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929826000015/0001599298-26-000015-index.htm) |
| 2024-12-31 | $0.00 | -$226.00M | -$221.31M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929826000015/0001599298-26-000015-index.htm) |
| 2023-12-31 | $0.00 | -$609.65M | -$614.93M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929826000015/0001599298-26-000015-index.htm) |
| 2022-12-31 | $705.00K | -$72.09M | -$78.78M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929825000048/0001599298-25-000048-index.htm) |
| 2021-12-31 | $1.81M | -$86.19M | -$88.60M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929823000034/0001599298-23-000034-index.htm) |
| 2020-12-31 | $860.00K | -$53.19M | -$52.70M | [10-K/A](https://www.sec.gov/Archives/edgar/data/1599298/000159929822000147/0001599298-22-000147-index.htm) |

## SMMT annual balance sheet

| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | $751.18M | $92.32M | $658.86M | [10-Q](https://www.sec.gov/Archives/edgar/data/1599298/000159929826000090/0001599298-26-000090-index.htm) |
| 2024-12-31 | $435.56M | $46.81M | $388.75M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929826000015/0001599298-26-000015-index.htm) |
| 2023-12-31 | $202.95M | $125.26M | $77.69M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929825000048/0001599298-25-000048-index.htm) |
| 2022-12-31 | $664.17M | $537.51M | $126.65M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929824000031/0001599298-24-000031-index.htm) |
| 2021-12-31 | $113.37M | $30.09M | $83.28M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929823000034/0001599298-23-000034-index.htm) |
| 2020-12-31 | $102.50M | $23.05M | $79.45M | [10-K/A](https://www.sec.gov/Archives/edgar/data/1599298/000159929822000147/0001599298-22-000147-index.htm) |

## SMMT annual cash flow

| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
| --- | --- | --- | --- | --- |
| 2025-12-31 | -$322.93M | -$657.00K | $617.53M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929826000015/0001599298-26-000015-index.htm) |
| 2024-12-31 | -$142.11M | -$139.00K | $381.23M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929826000015/0001599298-26-000015-index.htm) |
| 2023-12-31 | -$76.76M | -$128.00K | $86.51M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929826000015/0001599298-26-000015-index.htm) |
| 2022-12-31 | -$41.58M | -$624.00K | $620.24M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929825000048/0001599298-25-000048-index.htm) |
| 2021-12-31 | -$72.59M | -$306.00K | $77.92M | [10-K](https://www.sec.gov/Archives/edgar/data/1599298/000159929823000034/0001599298-23-000034-index.htm) |
| 2020-12-31 | -$48.11M | -$421.00K | $50.55M | [10-K/A](https://www.sec.gov/Archives/edgar/data/1599298/000159929822000147/0001599298-22-000147-index.htm) |

- [SMMT stock research](https://tradytics.com/research/SMMT)
- [SMMT financial summary](https://tradytics.com/research/SMMT/financials)
- [Read the data without JavaScript](https://tradytics.com/research/SMMT/fundamentals?snapshot=1)
